Albert A. Antolín
Impact in
-
- Computational Drug Discovery Methods
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Protein Degradation and Inhibitors 6
- Bioinformatics and Genomic Networks 4
- Genetics, Bioinformatics, and Biomedical Research 2
-
- Computational Drug Discovery Methods 16
- Co-authors
- Jordi Mestres (9 shared papers)Bissan Al‐Lazikani (13 shared papers)Paul Workman (10 shared papers)Joseph E Tym (4 shared papers)Costas Mitsopoulos (5 shared papers)Elizabeth A. Coker (4 shared papers)Núria López-Bigas (3 shared papers)David Tamborero (3 shared papers)
- Journals
- Nucleic Acids Research (6 papers)Cell chemical biology (4 papers)ACS Chemical Biology (3 papers)Cancer Research (2 papers)Cancer Cell (1 paper)
- Partner nations
- United KingdomSpainUnited States
In The Last Decade
Albert A. Antolín
29 papers receiving 972 citations
Peers
Comparison fields: 5 of 88
- Computational Theory and Mathematics 268
- Cancer Research 208
- Oncology 306
- Molecular Biology 671
- Immunology 76
Countries citing papers authored by Albert A. Antolín
This map shows the geographic impact of Albert A. Antolín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert A. Antolín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert A. Antolín more than expected).
Fields of papers citing papers by Albert A. Antolín
This network shows the impact of papers produced by Albert A. Antolín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert A. Antolín. The network helps show where Albert A. Antolín may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert A. Antolín, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 217 | |
| 2 | 2015 | 98 | |
| 3 | 2018 | 82 | |
| 4 | 2020 | 80 | |
| 5 | 2016 | 69 | |
| 6 | 2020 | 64 | |
| 7 | 2012 | 56 | |
| 8 | 2017 | 51 | |
| 9 | 2021 | 47 | |
| 10 | 2014 | 44 | |
| 11 | 2022 | 34 | |
| 12 | 2014 | 25 | |
| 13 | 2019 | 23 | |
| 14 | 2022 | 19 | |
| 15 | 2021 | 17 | |
| 16 | 2013 | 15 | |
| 17 | 2022 | 12 | |
| 18 | 2023 | 8 | |
| 19 | 2023 | 5 | |
| 20 | 2024 | 5 |
About Albert A. Antolín
Albert A. Antolín is a scholar working on Molecular Biology, Computational Theory and Mathematics, Oncology, Organic Chemistry and Spectroscopy, having authored 29 papers that have together received 990 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (16 papers), PARP inhibition in cancer therapy (8 papers), Protein Degradation and Inhibitors (6 papers), Click Chemistry and Applications (4 papers), Bioinformatics and Genomic Networks (4 papers), Cancer Genomics and Diagnostics (3 papers), Genetics, Bioinformatics, and Biomedical Research (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Computational Theory and Mathematics (268 citations), Cancer Research (208 citations), Oncology (306 citations), Molecular Biology (671 citations) and Immunology (76 citations). Albert A. Antolín has collaborated with scholars based in United Kingdom, Spain and United States. Frequent co-authors include Jordi Mestres, Bissan Al‐Lazikani, Paul Workman, Joseph E Tym, Costas Mitsopoulos, Elizabeth A. Coker, Núria López-Bigas, David Tamborero, M. Schroeder and Christian Perez-Llamas. Their work appears in journals such as Nucleic Acids Research, Cell chemical biology, ACS Chemical Biology, Cancer Research and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.